OT mobile menu

Search form


Cancer and Genetics

ASCO Calls for Better Regulation, Training and Research for Genetic and Genomic Testing

Oncologists need to be better prepared to interpret and explain gene test results to their patients. Image © vitstudio/ Shutterstock.com

Cancer and Genetics

Researchers at Tulane University are reporting on how cancer is able to overcome p53, a key tumor-suppressing protein.

Oncologists today now have a much greater understanding of the mutational landscape underlying some tumors. However, in many respects it is still a daunting task—one that may require more effective interpretation tools.

Among active or former smokers undergoing lung cancer screening, longer peripheral leukocyte telomere length is associated with an increased risk of lung cancer.

New data are suggesting that deciphering the genomic diversity and evolution of tumors may provide a basis for identifying new targets and designing improved personalized medicine strategies.

It may soon be possible to get rid of the “one-size-fits-all” approach when it comes to radiation therapy.

Patient enrollment has opened for the COMmunication and Education in Tumor Profiling COMET study, the ECOG-ACRIN Cancer Research Group has announced. The study will determine if online genetic self-education can reduce patients’ tumor gene testing-associated stress and anxiety.

Professor Mishra and his colleagues recently developed a program called Pipeline for Cancer Inference or PiCnIc for short that analyzes patient tumor sequencing data to create potential ways that the tumor may evolve and progress that is patient-personalized.


Subscribe to Cancer and Genetics on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.